Clearmind Medicine CMND
NASDAQ CMND
$6.00 +0.01 (+0.08%)
As of: Oct 22, 2026 · 3:27 PM EDT

Clearmind Medicine (CMND) Price to Sales (2025 - 2026)

Updated

Analysis

Clearmind Medicine (CMND) Price to Sales (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Clearmind Medicine 9,534.00 -39.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2026 0.03
Oct 31, 2025 0.24
Jul 31, 2025 0.49
Jan 31, 2025 0.48
API Access

Clearmind Medicine Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CMND&period=max&api_key=YOUR_API_KEY